The dual mechanisms of 99mTc-MIBI scintigraphy were used to predict and evaluate neoadjuvant chemotherapy for osteosarcoma
Conclusion99mTc-MIBI imaging is a useful tool for the evaluation of neoadjuvant chemotherapy in patients with osteosarcoma, and it has the dual value of predicting and evaluating tumor response to chemotherapy.
Source: Journal of Bone Oncology - Category: Cancer & Oncology Source Type: research
More News: Bone Cancers | Cancer & Oncology | Chemotherapy | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Osteosarcoma | Statistics | Study